|
|
|
Insider
Information: |
Sonsini Peter W. |
Relationship: |
10% Owner |
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
39 |
|
Direct
Shares |
66,219,175 |
|
Indirect Shares
|
287,129,918 |
|
|
Direct
Value |
$483,996,756 |
|
|
Indirect Value
|
$541,076,205 |
|
|
Total
Shares |
353,349,093 |
|
|
Total
Value |
$1,025,072,961 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
5
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
21.6%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
|
0 |
2015-03-11 |
18,750,000 |
Premium* |
|
Ardelyx Inc |
ARDX |
10% Owner |
|
0 |
2019-12-09 |
6,564,372 |
Premium* |
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
Synlogic Inc |
SYBX |
10% Owner |
2015-10-05 |
0 |
2018-01-26 |
4,228,940 |
Premium* |
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
24 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2020-09-14 |
745 |
2020-09-14 |
596 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2020-05-20 |
2,892,877 |
2018-04-23 |
3,312,877 |
Premium* |
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
339 |
2018-02-13 |
676 |
Premium* |
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
4,186,243 |
Premium* |
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
821 |
Premium* |
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
54 |
Premium* |
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2021-03-15 |
24,137,931 |
Premium* |
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
Reneo Pharmaceuticals, Inc. |
RPHM |
10% Owner |
2021-04-13 |
4,785,494 |
2021-04-13 |
0 |
Premium* |
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-02 |
270 |
Premium* |
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-05-31 |
26,306,693 |
2022-11-16 |
70 |
Premium* |
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2022-01-25 |
3,305,601 |
2021-12-27 |
0 |
Premium* |
|
Casper Sleep Inc. |
CSPR |
10% Owner |
2022-01-25 |
0 |
2022-01-25 |
0 |
Premium* |
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-02-08 |
6,432,762 |
2022-12-20 |
12 |
Premium* |
|
Senti Biosciences, Inc |
SNTI |
10% Owner |
2022-06-08 |
4,426,151 |
|
0 |
Premium* |
|
Zerofox Holdings Ord Shs |
ZFOX |
10% Owner |
2022-08-03 |
18,068,513 |
|
0 |
Premium* |
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
2023-01-03 |
0 |
2023-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RPHM |
Reneo Pharmaceuticals, In... |
10% Owner |
|
2021-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,118,828 |
4,118,828 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-24 |
4 |
A |
$0.00 |
$0 |
I/I |
30,821 |
821 |
0 |
- |
|
EAR |
Eargo, Inc. |
10% Owner |
|
2021-05-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,030,000) |
0 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
A |
$0.00 |
$0 |
I/I |
138,693 |
54 |
0 |
- |
|
DM |
Desktop Metal Ord Shs Cla... |
10% Owner |
|
2021-06-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,135,000) |
0 |
0 |
- |
|
BHG |
Bright Health Group Inc. |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
133,640,415 |
22,288,629 |
0 |
- |
|
GLUE |
Monte Rosa Therapeutics, ... |
10% Owner |
|
2021-06-28 |
4 |
A |
$0.00 |
$0 |
I/I |
6,642,298 |
6,642,298 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
68,959,606 |
6,086,208 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-08-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(71,468,726) |
0 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-08-02 |
4 |
A |
$0.00 |
$0 |
I/I |
71,468,726 |
6,086,208 |
0 |
- |
|
TRVI |
Trevi Therapeutics, Inc. |
10% Owner |
|
2021-10-18 |
4 |
B |
$0.00 |
$0 |
I/I |
1,851,852 |
7,789,850 |
1.42 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-10-27 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,449,600) |
6,811,008 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-10-27 |
4 |
A |
$0.00 |
$0 |
I/I |
21,744 |
10,872 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
21,744 |
21,744 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2021-11-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,449,600) |
6,086,208 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-01-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,223,741) |
0 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-01-28 |
4 |
A |
$0.00 |
$0 |
I/I |
366,880 |
139 |
0 |
- |
|
ACLX |
Arcellx, Inc. |
10% Owner |
|
2022-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,849,429 |
4,849,429 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-05-02 |
4 |
D |
$0.00 |
$0 |
I/I |
(24,180,253) |
0 |
0 |
- |
|
HOOD |
Robinhood Markets, Inc. |
Director |
|
2022-05-02 |
4 |
A |
$0.00 |
$0 |
I/I |
366,288 |
270 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,965,208) |
0 |
0 |
- |
|
AVEO |
Aveo Pharmaceuticals Inc |
10% Owner |
|
2022-10-19 |
4 |
A |
$0.00 |
$0 |
I/I |
4,013,874 |
24 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-11-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(11,867,242) |
0 |
0 |
- |
|
IONQ |
Ionq Ord Shs |
10% Owner |
|
2022-11-16 |
4 |
A |
$0.00 |
$0 |
I/I |
180,175 |
70 |
0 |
- |
|
AKUS |
Akouos, Inc. |
10% Owner |
|
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,294,207) |
0 |
0 |
- |
|
176 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|